Funding Opportunity PAR-18-424 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI Career Transition Award (K22) program is to provide highly qualified postdoctoral fellows in the NHLBI Division of Intramural Research the opportunity to transition their research programs as new investigators to extramural institutions. To achieve these objectives, the NHLBI Career Transition Award will support two phases of research: a mentored intramural phase (up to two years) and an extramural phase (three years), for a total of five years of combined support. Transition from the intramural phase of support to the extramural phase is not automatic. Approval of the transition will be based on the success of the awardee's research program during the mentored phase as determined by an NHLBI progress review, which will include an evaluation of a research plan to be carried out at the extramural institution. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary study to an ongoing clinical trial as lead investigator, should apply to the companion FOA (FOA #).

Funding Opportunity PAR-18-416 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI Career Transition Award (K22) program is to provide highly qualified postdoctoral fellows in the NHLBI Division of Intramural Research the opportunity to transition their research programs as new investigators to extramural institutions. To achieve these objectives, the NHLBI Career Transition Award will support two phases of research: a mentored intramural phase (up to two years) and an extramural phase (three years), for a total of five years of combined support. Transition from the intramural phase of support to the extramural phase is not automatic. Approval of the transition will be based on the success of the awardee's research program during the mentored phase as determined by an NHLBI progress review, which will include an evaluation of a research plan to be carried out at the extramural institution. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary study to an ongoing clinical trial as lead investigator, should apply to the companion FOA (TEMP-229).

Funding Opportunity PAR-18-415 from the NIH Guide for Grants and Contracts. This FOA invites applications for investigator-initiated, multi-center clinical trials involving three or more clinical centers. Proposed trials should be hypothesis-driven, have the potential to change clinical practice and/or public health, and focus on a disease relevant to the mission of NIDDK. Planning activities must be completed prior to submission and are not permitted under this FOA. Applicants who require a planning phase may first apply for an implementation planning cooperative agreement (U34; see PAR-18-xxx ). Consultation with NIDDK Scientific/Research staff is strongly encouraged prior to the submission of either a U34 or U01 application.

Funding Opportunity PAR-18-414 from the NIH Guide for Grants and Contracts. This FOA invites applications for investigator-initiated, multi-center observational studies involving three or more clinical centers. Proposed studies should be hypothesis-driven and focus on a disease relevant to the mission of NIDDK. Planning activities must be completed prior to submission and are not permitted under this FOA. Applicants who require a planning phase may first apply for an implementation planning cooperative agreement (U34; see PAR-18-xxx ). Consultation with NIDDK Scientific/Research staff is strongly encouraged prior to the submission of either a U34 or U01 application.

Funding Opportunity PAR-18-423 from the NIH Guide for Grants and Contracts. NIDDK supports investigator-initiated, multi-center (three or more centers) clinical studies through a two-part process that may include an implementation planning cooperative agreement (U34). The U34 is designed to: 1) Permit early peer review of the rationale for the proposed clinical study; 2) Permit assessment of the design and protocol of the proposed study; 3) Provide support for the development of documents needed for the conduct of the study, including a manual of operations; and 4) Support the development of other essential elements required for the conduct of the clinical study. The proposed clinical study should be hypothesis-driven and focus on a disease relevant to the mission of NIDDK. Consultation with NIDDK scientific staff is strongly encouraged prior to the submission of the U34 application.

Familiarity with sequence database analysis utilizing a variety of software programs. A minimum of 5 years of direct experience in bioinformatics is required....
From University of Wisconsin–Madison - Tue, 28 Nov 2017 02:16:31 GMT - View all Madison, WI jobs

Minimum of 5 years of relevant work experience (e.g., as a statistician / computational biologist / bioinformatician / data scientist), including deep expertise...
From Schneider - Mon, 27 Nov 2017 21:34:00 GMT - View all Green Bay, WI jobs

Notice NOT-OD-18-105 from the NIH Guide for Grants and Contracts

Notice NOT-ES-18-001 from the NIH Guide for Grants and Contracts

Notice NOT-NS-18-021 from the NIH Guide for Grants and Contracts

Notice NOT-HL-17-566 from the NIH Guide for Grants and Contracts

Notice NOT-NS-18-019 from the NIH Guide for Grants and Contracts

Notice NOT-OD-18-104 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-18-413 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages the submission of investigator-initiated research grant applications to support research investigating the epidemiology of alcohol use, alcohol-related harms, and alcohol use disorders and the prevention of underage drinking, alcohol-related harms, and alcohol use disorders.

Funding Opportunity PA-18-391 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages the submission of investigator-initiated research grant applications to support research investigating the epidemiology of alcohol use, alcohol-related harms, and alcohol use disorders and the prevention of underage drinking, alcohol-related harms, and alcohol use disorders.

Funding Opportunity PA-18-390 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages the submission of investigator-initiated research grant applications to support research investigating the epidemiology of alcohol use, alcohol-related harms, and alcohol use disorders and the prevention of underage drinking, alcohol-related harms, and alcohol use disorders.

Negotiable: Paramount Recruitment: Data Scientist - Bioinformatics 12 Month Contract - Germany A great opportunity has come available for a Postdoctoral Researcher in Data Science to join a global biopharmaceutical leader transforming the lives of those with severe diseases. The client fo Germany

Negotiable: Paramount Recruitment: Research Scientist - Bioinformatics 12 month Fixed-Term Contract A great opportunity has come available for a Bioinformatician, skilled in RNA Sequencing to join a global biopharmaceutical leader transforming the lives of those with severe diseases. The Slough, England

With at least 1 years of academic or industrial experience in Computer Sciences, Molecular Biology, Bioinformatics, Statistics, Computational Biology or a...
From Indiana University - Thu, 23 Nov 2017 09:29:53 GMT - View all Indiana jobs

Fairbanks School of Public Health, the Center for Computational Biology and Bioinformatics, and the Regenstrief Institute (an internationally recognized medical...
From Indiana University - Thu, 23 Nov 2017 09:28:12 GMT - View all Indiana jobs